AzTrials
AzTrials

Intubation; DifficultNCT02563301

Videolaryngoscopy in Patients With Cervical Spine Immobilisation

A study testing Laryngoscopy in people with Intubation; Difficult, run by NHS Tayside at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Tracheal intubation is more difficult in patients in whom cervical spine immobilisation is maintained during tracheal intubation. The McGrath Series 5 videolaryngoscope offers a potential solution. Read more about this study

Who is it for?
Ages 16 years and olderHealthy volunteers can take part
Conditions the study is for
Intubation; Difficult
What is being tested?
Laryngoscopy
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
49 participants
Where
1 siteUnited Kingdom
Study dates
Aug 2009to Nov 2012
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 years and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Elective procedure requiring tracheal intubation
  • Over 16 years of age

Who cannot join

  • Emergency procedure
  • Less than 16 years of age
  • Unable to consent
  • Symptomatic gastro-oesophageal reflux disease
  • Evidence of raised intracranial pressure
  • Known pharyngeal pathology

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • NHS Tayside

    Tayside

Other trials in United Kingdom

About this study

Official title: A Randomised Crossover Trial Comparing the McGrath Series 5 Videolaryngoscope With the Macintosh Laryngoscope in Patients With Cervical Spine Immobilisation

Tracheal intubation is more difficult in patients in whom cervical spine immobilisation is maintained during tracheal intubation. The McGrath Series 5 videolaryngoscope offers a potential solution. The relatively short radius of the blade curvature combined with the internal arrangement of optimal components means that the glottis can be seen without the need for alignment of the oral, pharyngeal and tracheal axes.

The investigators propose that the McGrath Series 5 videolaryngoscope will improve the view of the larynx in patients with limited neck movements, making intubation quicker, easier and possibly safer.

Being tested
Laryngoscopy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • LaryngoscopyDevice

    After establishing full monitoring, inducing general anaesthesia and ensuring paralysis, laryngoscopy is performed and the patient's trachea is intubated.

Study groups in NCT02563301
Study groupRoleWhat they receive
McGrath Series 5Active comparatorVideolaryngoscope used to perform indirect (video) laryngoscopy and tracheal intubation
Receives: Device: Laryngoscopy
MacintoshActive comparatorLaryngoscope used to perform direct laryngoscopy and tracheal intubation
Receives: Device: Laryngoscopy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cormack and Lehane laryngoscopy grade

    Measured: 5 minutes

Secondary outcomes (3)
  1. Time to intubation

    Measured: 5 minutes

  2. Rate of successful tracheal intubation

    Measured: 5 minutes

  3. Incidence of complications

    Measured: 5 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Sep 2015 (estimated)
  2. Study startAug 2009
  3. Primary completionNov 2012
  4. Study completionNov 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
49 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02563301
Sponsor's protocol ID
2008AN01
Status last verified
Sep 2015
First submitted
25 Sep 2015
Last updated
30 Sep 2015
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Laryngoscopy in people with Intubation; Difficult, run by NHS Tayside at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Sep 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cormack and Lehane laryngoscopy grade (time frame: 5 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Sep 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in